Highlights of ASH in Asia

Ultima Vez Modificado: 17 de enero del 2013

Share article


Dates: March 23-24, 2013
Location: Shanghai, China

Sponsoring Group: The American Society of Hematology

Web Page URL: www.hematology.org/calendar_HOAAsia

Topics Covered: Acute Myeloid Leukemia Bone Marrow Failure Chronic Lymphocytic Leukemia Disorders of Hemostasis Hematopoietic Stem Cell Transplantation Hodgkin and Non-Hodgkin Lymphoma Myelodysplastic Syndromes Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia Novel Treatments for Relapsed/Refractory Chronic Immune Thrombocytopenia Plasma Cell Disorders (Myeloma) Thrombosis and Anticoagulation Thrombotic Thrombocytopenic Purpura (TTP)/Hemolytic Uremic Syndrome (HUS) and Atypical HUS

Objectives: At Highlights of ASH you will:

  • Examine advances in clinical and translational hematologic research
  • Evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of people with blood diseases
  • Discuss new patient management and care strategies with leading faculty in the field

Fees: $125-275

Continuing Education: No

ASH: CALR Mutations ID'd in Myeloproliferative Neoplasms

Dec 11, 2013 - Many patients with myeloproliferative neoplasms without mutations in the Janus kinase 2 gene (JAK2) or in the thrombopoietin receptor gene (MPL) have mutations in the CALR gene encoding calreticulin, according to two studies published online Dec. 10 in the New England Journal of Medicine. The research was published to coincide with presentation at the annual meeting of the American Society of Hematology, held from Dec. 7 to 10 in New Orleans.

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información